EUVIMEDEUVIMED entdecken
Open Access

Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers

Juan Cheng iD, Peng Wu iD, Chenwen Li iD, Ying Han, Menglong Sun, Yin Dou, Sheng Chen iD, Jianxiang Zhang iD

Science Advances · 16.01.2026 · 12 (3)

DOI: 10.1126/sciadv.aea2989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 16.01.2026. Verfasst von Juan Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Chongqing Key Laboratory of Maternal and Fetal Medicine, The First Affiliated Hospital of Chongqing Medical …. Hauptthemen laut MEDLINE: Peptides, Inflammation, Colitis, Anti-Inflammatory Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing, Innovation Capability Support Program of Shaanxi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral delivery of peptide therapeutics remains challenging due to gastrointestinal (GI) degradation and poor intestinal absorption. Here, we propose a self-immolative peptide prodrug conjugate (SIPPC) platform for inflammation-targeted oral delivery, integrating a hydrophilic polyethylene glycol segment, a reactive oxygen species (ROS)–responsive hydrophobic self-immolative module, and a hydrolyzable scaffold, which collectively enable spontaneous assembly into micelle-like nanoparticles. Using three anti-inflammatory peptides (KPV, Ac-QAW, and IRW), we demonstrated that the engineered conjugates exhibit remarkable GI stability, efficient mucus penetration, and ROS-responsive release at inflamed sites. In colitis mice, the KPV-based conjugate (proKPV) achieved a 3.8-fold greater colonic accumulation than free KPV, with enhanced efficacy even at a 20-fold lower dose. Beyond therapeutic effects in the colitis model, oral proKPV substantially accumulated in inflamed lungs and exhibited potent anti-inflammatory efficacy in mice with acute lung injury. Ac-QAW and IRW-based conjugates exhibited comparable benefits, underscoring SIPPC as a transformative paradigm for oral peptide therapeutics, offering substantial promise for clinical translation in inflammatory disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesInflammationColitisAnti-Inflammatory AgentsDrug Delivery SystemsGastrointestinal TractAnimalsAdministration, OralMiceReactive Oxygen SpeciesProdrugsDisease Models, AnimalHumansNanoparticlesPolyethylene Glycols

Substanzen

PeptidesAnti-Inflammatory AgentsReactive Oxygen SpeciesProdrugsPolyethylene Glycols

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Chongqing Key Laboratory of Maternal and Fetal Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
  • Department of Pharmaceutics, College of Pharmacy, Third Military Medical University (Army Medical University), Chongqing 400038, China.
  • College of Pharmacy, Hanzhong Vocational and Technical College, Hanzhong, Shaanxi 723000, China.
  • Yu-Yue Pathology Scientific Research Center, 313 Gaoteng Avenue, Jiulongpo District, Chongqing 400039, China.
  • State Key Laboratory of Trauma and Chemical Poisoning, Third Military Medical University (Army Medical University), Chongqing 400038, China.
  • Department of Pediatrics, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.

ORCID-Profile: Juan Cheng, Peng Wu, Chenwen Li, Sheng Chen, Jianxiang Zhang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Chongqing
  • Innovation Capability Support Program of Shaanxi
  • Key Medical Program Integrated by Chongqing Science and Technology Bureau and Chongqing Health Commission
  • Key Program for Technological Innovation & Application Development of Chongqing
  • New Chongqing Youth Innovative Talent Program
  • Graduate Supervisor Team Program of Chongqing in 2022

Zitieren

APA

Cheng, J., Wu, P., Li, C., Han, Y., Sun, M., Dou, Y., Chen, S., & Zhang, J. (2026). Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers. Science Advances, 12(3). https://doi.org/10.1126/sciadv.aea2989

Vancouver

Cheng J, Wu P, Li C, Han Y, Sun M, Dou Y, et al. Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers. Science Advances. 2026;12(3). doi:10.1126/sciadv.aea2989

BibTeX
@article{Cheng2026,
  author = {Cheng, Juan and Wu, Peng and Li, Chenwen and Han, Ying and Sun, Menglong and Dou, Yin and Chen, Sheng and Zhang, Jianxiang},
  title = {Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {3},
  doi = {10.1126/sciadv.aea2989}
}
Kostenlos starten →